Mirae Asset Global Investments Co., Ltd. - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 69 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$660,000
-53.0%
901,835
-26.8%
0.00%
-50.0%
Q2 2022$1,405,000
-72.5%
1,232,456
-50.5%
0.00%
-20.0%
Q1 2022$5,106,000
+29.6%
2,490,482
+82.0%
0.01%
-37.5%
Q4 2021$3,941,000
-31.4%
1,368,439
+1.1%
0.01%
-46.7%
Q3 2021$5,741,000
-33.8%
1,353,929
-17.4%
0.02%
-37.5%
Q2 2021$8,667,000
+534.5%
1,638,400
+457.6%
0.02%
+380.0%
Q1 2021$1,366,000
-36.3%
293,841
-54.8%
0.01%
-37.5%
Q4 2020$2,145,000
+59.1%
649,881
+59.6%
0.01%
+14.3%
Q3 2020$1,348,000
+13.4%
407,258
+15.4%
0.01%0.0%
Q2 2020$1,189,000
-1.1%
352,792
+12.4%
0.01%
-22.2%
Q1 2020$1,202,000
-34.3%
313,827
+3.6%
0.01%
-18.2%
Q4 2019$1,829,000
-55.6%
302,795
-44.4%
0.01%
-62.1%
Q3 2019$4,116,000
-24.9%
544,408
+34.6%
0.03%
-23.7%
Q2 2019$5,482,000
+21.3%
404,560
+12.0%
0.04%
-37.7%
Q4 2017$4,520,000
+59.7%
361,062
+6.6%
0.06%
+17.3%
Q3 2017$2,830,000
-45.0%
338,552
+11.7%
0.05%
-41.6%
Q2 2017$5,144,000303,1100.09%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 2,679,457$20,257,0000.73%
Portolan Capital Management 777,293$5,876,0000.66%
CAMPBELL CAPITAL MANAGEMENT INC 110,451$835,0000.62%
ZEKE CAPITAL ADVISORS, LLC 402,212$3,041,0000.27%
Leap Investments LP 46,084$348,0000.17%
Bernardo Wealth Planning LLC 26,419$199,0000.14%
Claraphi Advisory Network, LLC 14,744$111,0000.07%
Sterling Investment Advisors, Ltd. 11,000$83,0000.04%
A.R.T. Advisors, LLC 81,372$615,0000.03%
Mirae Asset Global Investments Co., Ltd. 544,408$4,116,0000.03%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders